BioMarin said it expects to have pre-tax charges of around $30 million as a result of the latest round of job cuts, adding that all the affected employees were notified by 28th August and the ...

In this article, we are going to take a look at where BioMarin Pharmaceutical Inc ... based company has grown in size and success, senior employees at its European division have felt more ...

Net income was up a robust 525% year over year, rising to $125 million. BioMarin Pharmaceutical exceeded earnings and revenue expectations in its Q4 2024 financial results. BioMarin Pharmaceutical ...

BioMarin Pharmaceutical (NASDAQ:BMRN), a leader in developing innovative therapies for rare genetic disorders, reported fourth-quarter 2024 financial results on Wednesday, Feb. 19, that topped ...